Categories
Issue 72 September 2024

New respiratory syncytial virus (RSV) passive immunisation programme

The HSE is offering a new respiratory syncytial virus (RSV) immunisation programme providing the monoclonal antibody Nirsevimab to newborn infants born during the RSV season’ (from September 2024 until February 2025) in Irish maternity hospitals. Premature babies (born before 30 weeks gestation or less than 1.25kg at birth) will also be offered nirsevimab. This is […]

Categories
Issue 72 September 2024

Reminder to advocate for Whooping Cough Vaccination in babies and pregnant women

As healthcare professionals, our role extends beyond treating ailments; we are also educators and advocates for preventative care. One of the critical areas where our guidance can make a profound difference is in the prevention of pertussis, commonly known as whooping cough in infants. We have seen an increase in pertussis in Ireland and there […]

Categories
Issue 72 September 2024

Publication of the National Immunisation Office Strategic Plan 2024-2027

Dr Lucy Jessop, Director of the National Immunisation Office. I am pleased to announce the publication of the National Immunisation Office (NIO) Strategic plan.  The release of this report marks a key milestone in public health, outlining goals to help achieve equity and excellence in our public immunisation programmes. This comprehensive strategy serves as a […]